Beyond Analysis has launched a new sister company Beyond AML which will assist financial institutions to leverage applied intelligence, data analytics and machine learning to optimise their end-to-end ...
Intellia’s CRISPR/Cas9 proprietary process produces multiple, highly efficient sequential edits in T cells that have superior function and minimal translocations, compared to results from standard T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback